Skip to main content
logo
NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0640
-0.0010 (-1.54%)
Aug 26, 2026, 1:01 PM AEST

ASX:NSB Revenue

In the fiscal year ending June 30, 2026, NeuroScientific Biopharmaceuticals had annual revenue of 629.40K AUD. NeuroScientific Biopharmaceuticals had revenue of 317.91K in the half year ending December 31, 2025.

Revenue
629.40K
Revenue Growth
+278.98%
P/S Ratio
39.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.94M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2026629.40K--
Jun 30, 2025---
Jun 30, 20242.21M-2.74M-55.34%
Jun 30, 20234.95M--
Jun 30, 2022---
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
EZZ Life Science Holdings61.40M
Radiopharm Theranostics16.28M
Neurotech International7.07M
Neurizon Therapeutics5.98M
Imugene3.94M
Noxopharm3.40M
Proteomics International Laboratories3.21M
Argenica Therapeutics1.01M
Revenue Rankings

NeuroScientific Biopharmaceuticals News

More News